Canadian Paper Pushes Back On Biosimilar Switching

Brand-Backed Bodies’ Position Statement Expresses Caution

 
• By Dave Wallace

A joint position statement published by originator-backed bodies the Canadian Association of Gastroenterology and Crohn’s and Colitis Canada has expressed caution over so-called ‘non-medical switching’ of IBD patients from brand biologics to biosimilars.

Light_Switch
The Canadian position statement is cautious about switches • Source: Shutterstock

More from Biosimilars

More from Products